GO:0030187 melatonin biosynthetic process: Circadian Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030187 (melatonin biosynthetic process) describes the enzymatic steps that convert serotonin to N-acetyl-5-methoxytryptamine (melatonin).
• The pathway is best known for its role in circadian rhythm regulation, but melatonin also acts as a broad-spectrum antioxidant and neuroprotectant.
• Key enzymes include arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole O-methyltransferase (HIOMT/ASMT), which catalyze the two terminal reactions.
• Melatonin biosynthesis is tightly regulated by light/dark cycles and is disrupted in conditions such as autism spectrum disorder and neurodegenerative diseases.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of melatonin pathway genes in disease and physiology.
• Targeting melatonin biosynthesis is being explored for therapeutic intervention in oxidative stress, cardiotoxicity, and reproductive toxicity.
Description
Melatonin (N-acetyl-5-methoxytryptamine) is a pleiotropic hormone primarily synthesized in the pineal gland, where its production follows a circadian rhythm and is suppressed by light. The Gene Ontology term GO:0030187, melatonin biosynthetic process, defines the chemical reactions and pathways that result in the formation of melatonin from its precursors. Beyond its canonical role in sleep-wake regulation, melatonin is now recognized as a potent antioxidant, anti-inflammatory agent, and regulator of mitochondrial function. Understanding the biosynthesis of melatonin is therefore critical for researchers studying circadian biology, neuroprotection, and metabolic health. The pathway involves a series of enzymatic steps that convert tryptophan to serotonin and then to melatonin, with arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole O-methyltransferase (HIOMT/ASMT) serving as key regulators. Disruptions in melatonin biosynthesis have been linked to autism spectrum disorder, aging-related neurodegeneration, and cardiovascular complications. This article provides a research-grade overview of GO:0030187, covering its molecular mechanism, key genes, disease relevance, and modern CRISPR-based methods for functional interrogation.
melatonin biosynthetic process At A Glance
| GO ID | GO:0030187 |
|---|---|
| GO term | melatonin biosynthetic process |
| Ontology | biological_process |
| Synonym | melatonin anabolism, melatonin biosynthesis, melatonin formation, melatonin synthesis |
| Major function | Production of melatonin from serotonin via enzymatic acetylation and methylation |
| Key enzymes | AANAT (arylalkylamine N-acetyltransferase), ASMT/HIOMT (acetylserotonin O-methyltransferase) |
| Location | Primarily pineal gland, also retina and gastrointestinal tract |
| Regulation | Circadian clock-controlled, light-sensitive, and influenced by norepinephrine signaling |
What Is GO:0030187?
GO:0030187, melatonin biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of melatonin (N-acetyl-5-methoxytryptamine). This biological process encompasses the enzymatic conversion of precursor molecules, typically starting from serotonin, into the final melatonin product. The term is synonymous with melatonin anabolism, melatonin biosynthesis, melatonin formation, and melatonin synthesis.
Why Is melatonin biosynthetic process Important in Cell Biology?
Melatonin biosynthesis is essential for maintaining circadian rhythms, and its dysregulation is implicated in a wide range of disorders, from sleep disturbances and autism spectrum disorder to neurodegeneration and cardiovascular disease. Because melatonin also functions as a powerful antioxidant, understanding its biosynthetic pathway offers opportunities for therapeutic modulation in oxidative stress-related conditions.
• Regulates circadian rhythms and sleep-wake cycles.
• Acts as a broad-spectrum antioxidant, protecting against oxidative damage.
• Plays a role in neuroprotection and retardation of brain aging.
• Disrupted in autism spectrum disorder and other neurodevelopmental conditions.
• Involved in cardiovascular protection, including doxorubicin-induced cardiotoxicity.
• Modulates reproductive function and protects against lipotoxicity in testes.
• Serves as a biomarker for circadian disruption in shift work and aging.
• Target for therapeutic intervention in metabolic and inflammatory diseases.
• Key to understanding pineal gland physiology and photoperiodic responses.
• Enables research on chronotherapy and personalized medicine.
What Happens During melatonin biosynthetic process?
Tryptophan to Serotonin Conversion
In simple terms: The body first turns tryptophan into serotonin, the starting material for melatonin.
Melatonin biosynthesis begins with the amino acid tryptophan, which is converted to 5-hydroxytryptophan by tryptophan hydroxylase and then to serotonin by aromatic amino acid decarboxylase. This step is common to the synthesis of other indoleamines and is not unique to melatonin production. Serotonin serves as the immediate precursor for the subsequent acetylation reaction.
Acetylation of Serotonin by AANAT
In simple terms: An enzyme called AANAT adds an acetyl group to serotonin, making N-acetylserotonin.
The rate-limiting step in melatonin biosynthesis is the acetylation of serotonin to N-acetylserotonin, catalyzed by arylalkylamine N-acetyltransferase (AANAT). AANAT activity is tightly regulated by circadian clock mechanisms and light exposure, with enzyme levels peaking at night. This step is critical for controlling the overall rate of melatonin production.
Methylation by ASMT/HIOMT
In simple terms: Another enzyme, ASMT, adds a methyl group to N-acetylserotonin to produce melatonin.
The final step is the O-methylation of N-acetylserotonin to melatonin, catalyzed by acetylserotonin O-methyltransferase (ASMT, also known as HIOMT). This enzyme transfers a methyl group from S-adenosylmethionine to the hydroxyl group of N-acetylserotonin. ASMT is expressed in the pineal gland and retina, and its activity is also subject to circadian regulation.
Circadian and Light Regulation
In simple terms: The whole process is switched on at night and off during the day by the body's clock and light signals.
Melatonin biosynthesis is under strict circadian control. In the pineal gland, norepinephrine released from sympathetic neurons at night stimulates beta-adrenergic receptors, leading to increased cAMP and activation of AANAT transcription. Light exposure at night rapidly suppresses melatonin production by inhibiting this pathway. This regulation ensures that melatonin levels peak during the dark phase and are low during the day.
Key Genes Involved in GO:0030187 melatonin biosynthetic process
The following genes encode enzymes and regulatory proteins directly involved in the melatonin biosynthetic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AANAT | Rate-limiting enzyme converting serotonin to N-acetylserotonin | Central to circadian regulation; knockout models show abolished melatonin rhythm |
| ASMT | Catalyzes final methylation step to form melatonin | Mutations linked to autism spectrum disorder and melatonin deficiency |
| TPH1 | Tryptophan hydroxylase 1, converts tryptophan to 5-hydroxytryptophan | Peripheral serotonin synthesis; affects melatonin precursor availability |
| TPH2 | Tryptophan hydroxylase 2, neuronal isoform | Brain serotonin synthesis; impacts melatonin production in pineal gland |
| DDC | Aromatic amino acid decarboxylase, converts 5-HTP to serotonin | Provides serotonin precursor for melatonin synthesis |
| SIRT1 | NAD+-dependent deacetylase, modulates oxidative stress and melatonin signaling | Mediates protective effects of melatonin in cardiotoxicity and testicular lipotoxicity |
| Nrf2 | Transcription factor regulating antioxidant response | Activated by melatonin to protect against doxorubicin-induced cardiotoxicity |
| MT1 | Melatonin receptor 1 | Mediates melatonin signaling; feedback regulation of biosynthesis |
| MT2 | Melatonin receptor 2 | Mediates melatonin signaling in circadian and antioxidant pathways |
| CLOCK | Core circadian clock transcription factor | Regulates AANAT expression and melatonin rhythm |
| BMAL1 | Core circadian clock transcription factor | Partners with CLOCK to drive rhythmic AANAT transcription |
| PER1 | Circadian clock repressor | Modulates clock feedback and melatonin synthesis timing |
| CRY1 | Circadian clock repressor | Influences light-induced suppression of melatonin |
| CREB | cAMP response element-binding protein | Mediates norepinephrine-induced AANAT transcription |
| PKA | Protein kinase A | Activated by cAMP to stimulate AANAT expression |
| GNAQ | G protein subunit alpha q | May modulate pineal signaling; less characterized in melatonin synthesis |
| HIOMT | Alternative name for ASMT | Same as ASMT; used interchangeably in literature |
How Is melatonin biosynthetic process Regulated?
Melatonin biosynthesis is primarily regulated at the transcriptional and post-translational levels by the circadian clock and light signals. In the pineal gland, the suprachiasmatic nucleus (SCN) sends circadian signals via sympathetic neurons, leading to nocturnal norepinephrine release. Norepinephrine binds to beta-adrenergic receptors, activating adenylyl cyclase and increasing cAMP, which in turn activates PKA and CREB. CREB induces AANAT transcription, and AANAT protein is stabilized by binding to 14-3-3 proteins. Light exposure at night triggers degradation of AANAT, rapidly shutting down melatonin production. Additionally, SIRT1 and Nrf2 pathways have been implicated in modulating the protective effects of melatonin, though their direct role in biosynthesis is less clear.
melatonin biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| AANAT | Circadian rhythm sleep disorders | Knockout mouse model to assess melatonin rhythm and sleep behavior |
| ASMT | Autism spectrum disorder | Point mutation knock-in in cell lines to study enzyme activity |
| SIRT1 | Doxorubicin-induced cardiotoxicity | Cardiomyocyte-specific knockout or overexpression in mice |
| Nrf2 | Oxidative stress and cardiovascular disease | Knockout mice to test melatonin-mediated protection |
| MT2 | Metabolic syndrome and circadian disruption | Knock-in of human variants in zebrafish or mice |
Circadian Rhythm Disorders and Sleep Disturbances
Disruption of melatonin biosynthesis leads to circadian rhythm sleep disorders, including delayed sleep phase syndrome and shift work disorder. Reduced nocturnal melatonin levels are associated with insomnia and impaired sleep quality. Genetic variants in AANAT and ASMT have been linked to altered melatonin production and sleep phenotypes.
Autism Spectrum Disorder
Children with autism spectrum disorder often exhibit abnormal melatonin levels, with low nocturnal melatonin being a common finding. Polymorphisms in ASMT have been associated with autism, suggesting that impaired melatonin biosynthesis may contribute to the pathophysiology of the disorder. Melatonin supplementation has been used to improve sleep in this population.
Neurodegeneration and Brain Aging
Age-related decline in melatonin production is associated with increased oxidative stress and neurodegeneration. Melatonin and its metabolites protect against amyloid-beta toxicity and tau hyperphosphorylation, and reduced melatonin levels are observed in Alzheimer's disease and Parkinson's disease. Enhancing melatonin biosynthesis or supplementation may retard brain aging.
Cardiovascular and Reproductive Toxicity
Melatonin protects against doxorubicin-induced cardiotoxicity by activating SIRT1/Nrf2 signaling and inhibiting oxidative stress, pyroptosis, and apoptosis. In the testes, melatonin attenuates palmitic acid-induced lipotoxicity and DNA damage via a SIRT1-dependent mechanism. These findings highlight the therapeutic potential of targeting melatonin biosynthesis or signaling in cardiovascular and reproductive disorders.
From melatonin biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does AANAT knockout abolish melatonin production? | AANAT knockout mouse or cell line |
| How do ASMT mutations affect enzyme kinetics? | Point mutation knock-in in HEK293 cells |
| Can overexpression of AANAT increase melatonin levels? | AANAT overexpression in pinealocyte cultures |
| What is the effect of SIRT1 on melatonin-mediated protection? | SIRT1 knockout cardiomyocytes |
| Does Nrf2 mediate melatonin's cardioprotective effects? | Nrf2 knockout mouse model |
| How does circadian clock regulate AANAT transcription? | CRISPR knock-in of tagged AANAT for live imaging |
How to Study the melatonin biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Determine necessity of AANAT/ASMT in melatonin synthesis |
| Point mutation knock-in | Effect of specific variants | Model ASMT mutations linked to autism |
| Overexpression | Gain of function | Increase melatonin production in cell culture |
| Tagged knock-in | Protein localization and dynamics | Live imaging of AANAT in pinealocytes |
| RNA-seq | Transcriptional changes | Identify clock-controlled genes in melatonin pathway |
| Proteomics | Protein expression and modifications | Assess AANAT stability and post-translational regulation |
| ELISA | Melatonin concentration | Quantify melatonin in culture media or serum |
| Luciferase reporter | Promoter activity | Measure AANAT promoter response to cAMP |
CRISPR-Cas9 Knockout Studies
CRISPR-Cas9 knockout of AANAT or ASMT in cell lines or animal models allows researchers to determine the necessity of these enzymes for melatonin production. Knockout models can be used to measure residual melatonin levels and assess downstream effects on circadian rhythms and oxidative stress.
Point Mutation and Knock-in Models
Introducing specific point mutations in ASMT or AANAT via CRISPR knock-in enables the study of enzyme variants associated with human diseases such as autism. These models help establish causality between genetic variants and altered melatonin biosynthesis.
Overexpression and Tagged Knock-in
Overexpression of AANAT or ASMT using CRISPR activation or lentiviral vectors can boost melatonin production in vitro and in vivo. Tagged knock-in of these enzymes with fluorescent proteins allows real-time imaging of their localization and dynamics in pinealocytes.
Transcriptomic and Proteomic Profiling
RNA-seq and proteomics can be used to profile gene expression changes in response to melatonin pathway perturbations. These methods identify downstream targets and feedback mechanisms, such as SIRT1 and Nrf2 pathways.
How CRISPR Can Be Used to Study GO:0030187 melatonin biosynthetic process
Knockout
CRISPR knockout of AANAT or ASMT is used to create melatonin-deficient models. These models are essential for studying the physiological consequences of melatonin loss, such as disrupted circadian rhythms and increased oxidative stress.
Point Mutation
Point mutations in ASMT identified in autism patients can be introduced via CRISPR to study their impact on enzyme activity and melatonin production. This approach provides direct causal evidence linking genetic variants to biochemical defects.
Knock-in
Knock-in of tagged AANAT or ASMT allows for visualization and tracking of these enzymes in live cells. This helps researchers understand their subcellular localization and interactions with other proteins.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of AANAT or ASMT can enhance melatonin biosynthesis. This is useful for producing melatonin in heterologous systems or for therapeutic applications.
How EDITGENE Supports melatonin biosynthetic process Research
Researchers studying melatonin biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in melatonin production, circadian regulation, or disease protection. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for melatonin biosynthetic process research.
Frequently Asked Questions About melatonin biosynthetic process
What is GO:0030187?
GO:0030187 is the Gene Ontology term for melatonin biosynthetic process, describing the chemical reactions and pathways that produce melatonin from precursors.
What genes are involved in melatonin biosynthetic process?
Key genes include AANAT, ASMT, TPH1, TPH2, and DDC, which encode enzymes that convert tryptophan to melatonin.
What is the rate-limiting enzyme in melatonin synthesis?
AANAT (arylalkylamine N-acetyltransferase) catalyzes the rate-limiting step by acetylating serotonin to N-acetylserotonin.
How is melatonin biosynthesis regulated?
It is regulated by the circadian clock and light via norepinephrine signaling, which controls AANAT transcription and stability.
What diseases are associated with defective melatonin biosynthesis?
Disorders include circadian rhythm sleep disorders, autism spectrum disorder, neurodegeneration, and cardiovascular toxicity.
Can CRISPR be used to study melatonin biosynthesis?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in melatonin pathways.
What is the role of ASMT in melatonin synthesis?
ASMT (acetylserotonin O-methyltransferase) catalyzes the final methylation step to produce melatonin from N-acetylserotonin.
How does melatonin act as an antioxidant?
Melatonin and its metabolites scavenge free radicals and upregulate antioxidant enzymes like SIRT1 and Nrf2.
What are the symptoms of melatonin deficiency?
Symptoms include sleep disturbances, circadian misalignment, and increased oxidative stress, often seen in aging and autism.
How can I model melatonin biosynthesis in the lab?
Use CRISPR knockout or overexpression of AANAT/ASMT in cell lines, followed by melatonin quantification via ELISA or LC-MS.
Conclusion
GO:0030187 melatonin biosynthetic process is a fundamental biological pathway with broad implications for circadian biology, neuroprotection, and disease. The enzymatic steps catalyzed by AANAT and ASMT are tightly regulated by the circadian clock and light, and their dysfunction is linked to sleep disorders, autism, neurodegeneration, and cardiovascular toxicity. Advances in CRISPR-based models are enabling precise dissection of these mechanisms, offering new avenues for therapeutic intervention. EDITGENE's comprehensive CRISPR services support researchers in uncovering the roles of melatonin pathway genes and translating these findings into clinical applications.
References
- 1. Vasey C et al.. 2021. Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin.. Nutrients 13(10) PMID: 34684482
- 2. Reiter RJ et al.. 2014. Melatonin: exceeding expectations.. Physiology (Bethesda) 29(5):325-33 PMID: 25180262
- 3. Reiter RJ et al.. 2016. Melatonin as an antioxidant: under promises but over delivers.. J Pineal Res 61(3):253-78 PMID: 27500468
- 4. Lalanne S et al.. 2021. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.. Int J Mol Sci 22(3) PMID: 33540815
- 5. Bocheva G et al.. 2024. The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging.. Int J Mol Sci 25(10) PMID: 38791160
- 6. Jia M et al.. 2025. Melatonin: beyond circadian regulation - exploring its diverse physiological roles and therapeutic potential.. Sleep Med Rev 82:102123 PMID: 40617069
- 7. Zhang W et al.. 2023. Melatonin alleviates doxorubicin-induced cardiotoxicity via inhibiting oxidative stress, pyroptosis and apoptosis by activating Sirt1/Nrf2 pathway.. Biomed Pharmacother 162:114591 PMID: 36965257
- 8. Xu D et al.. 2020. Melatonin protects mouse testes from palmitic acid-induced lipotoxicity by attenuating oxidative stress and DNA damage in a SIRT1-dependent manner.. J Pineal Res 69(4):e12690 PMID: 32761924
